Ian Ganly is an Otolaryngologist in New York, New York. Dr. Ganly is rated as an Elite provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Tongue Cancer, Thyroidectomy, and Laryngectomy.

Sanford Dubner is an Otolaryngologist in Lake Success, New York. Dr. Dubner has been practicing medicine for over 43 years and is rated as a Distinguished provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Thyroid Nodule, Thyroid Cancer, Hyperparathyroidism, Thyroidectomy, and Thymectomy.

Laura Sznyter is an Otolaryngologist in Great Neck, New York. Dr. Sznyter is rated as a Distinguished provider by MediFind in the treatment of Medullary Thyroid Carcinoma. Her top areas of expertise are Familial Isolated Hyperparathyroidism, Osteitis Fibrosa, Neonatal Severe Hyperparathyroidism, Parathyroidectomy, and Thyroidectomy.

Ashok Shaha is a General Surgeon in New York, New York. Dr. Shaha is rated as an Elite provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.

Robert Tuttle is an Endocrinologist in New York, New York. Dr. Tuttle is rated as an Elite provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, Thyroidectomy, and Gastrostomy.

Brian Untch is a Surgical Oncologist and a General Surgeon in New York, New York. Dr. Untch is rated as an Elite provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Thyroid Nodule, Pancreaticoduodenectomy, and Parathyroidectomy. Dr. Untch is currently accepting new patients.

Eric Sherman is an Oncologist in New York, New York. Dr. Sherman is rated as an Elite provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Carcinoma, Gastrostomy, and Liver Embolization.

James Fagin is an Endocrinologist in New York, New York. Dr. Fagin is rated as an Elite provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, Medullary Thyroid Carcinoma, and Thyroidectomy.

Kepal Patel is a Surgical Oncologist and a General Surgeon in New York, New York. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, Parathyroidectomy, and Thyroidectomy.

Dr. Bhuvanesh Singh, a board-certified otolaryngologist and physician scientist with a distinction in research, specializes in head and neck surgery and reconstruction with a particular expertise in skin cancers. He joins Northwell after 27 years at Memorial Sloan-Kettering Cancer Center, where he served as the director of Laboratory of Epithelial Cancer Biology and founder and co-director of the Advanced Skin Cancer Management and Prevention Program. A recognized leader in his field, Dr. Singh has served on the AJCC staging and NCCN guideline committees. He has published over 300 peer-reviewed manuscripts, 30 book chapters, and several textbooks, including one of the leading textbooks in head and neck oncology. He has delivered over 500 lectures worldwide. Additionally, as an NIH-funded researcher, he developed a novel antineoplastic compound that is currently being codeveloped with a pharmaceutical company for human use.Dr. Singh has performed over 10,000 surgical procedures, the experience from which has allowed him to develop innovative surgical approaches that have significantly enhanced outcomes for the many common head and neck oncological and reconstructive procedures such as thyroidectomy, neck dissection, and oral cavity and scalp reconstruction. His combined expertise in cancer ablation and facial cosmetic and reconstructive surgery enables him to optimize cancer treatment while achieving excellent cosmetic and functional results for his patients. Dr. Singh values the doctor-patient relationship, treating every patient as he would a family member. He has developed evidence-based strategies to enhance this relationship, emphasizing effective communication and care among all team members. By prioritizing holistic care and collaborative approaches, Dr. Singh aims to ensure that each patient feels valued and supported throughout their treatment journey. Dr. Singh is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Acinic Cell Carcinoma of Salivary Glands, Tissue Biopsy, and Thyroidectomy.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy.

Lucio Pereira is an Otolaryngologist in New Hyde Park, New York. Dr. Pereira is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Oral Squamous Cell Carcinoma, Mikulicz Disease, Tongue Cancer, Gastrostomy, and Laryngectomy.

Varvara Alexiadis is an Endocrinologist in Bayside, New York. Dr. Alexiadis is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. Her top areas of expertise are Hashimoto Thyroiditis, IPEX Syndrome, Autoimmune Polyglandular Syndrome Type 2, and Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED).

Dev Kamdar is an Otolaryngologist in New Hyde Park, New York. Dr. Kamdar is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Mikulicz Disease, Gastrostomy, and Laryngectomy.

Barry Schuval is an Endocrinologist in New Hyde Park, New York. Dr. Schuval is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Maturity Onset Diabetes of the Young, Thyroid Nodule, Hypothyroidism, and Type 2 Diabetes (T2D).

David Zeltsman is a Thoracic Surgeon in New Hyde Park, New York. Dr. Zeltsman is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Lung Nodules, Pleuropulmonary Blastoma, Lung Cancer, Gastrostomy, and Thymectomy.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Laryngeal Cancer, Adenoid Cystic Carcinoma, Throat Cancer, Teratocarcinosarcoma, and Vertebroplasty.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration.

Rachelle Bitton is an Endocrinologist in New Hyde Park, New York. Dr. Bitton is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. Her top areas of expertise are Obesity in Children, Hashimoto Thyroiditis, Melorheostosis, and Melorheostosis with Osteopoikilosis.